hotspot -WSS

hotspot

author：explore 2025-08-23 23:20:11 - browse：44782

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Medicare drug price negotiation hearing pits pharma v Biden admin

entertainment

WSS

Dispute over threat of extinction posed by artificial intelligence looms over surging industry

Harvard's David Sinclair gets blowback over aging

IVF doctors demand details after CooperSurgical lawsuit

Ozempic has benefits for kidney disease as well as diabetes

Hey, doctors: Don't be no

EMA weighs against approval for Mirati's lung cancer drug

leisure time

hotspot

Wikipedia

Jerome Adams on the need for new antivirals for Covid

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

Affirmative action in medical school literally saved lives

For AI in health care standards, federal regulators join with industry group

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout Newsletter: BridgeBio, Akero, and human embryo models

Dobbs anniversary: the lost opportunity of abortion as health care

It's time to take a new tack for treating Alzheimer's

Peter Hotez and the public health issue of online harassment

What is artificial intelligence? Experts weigh in

focus

IVF doctors demand details after CooperSurgical lawsuit

Longer MASH drug regimen improved liver, Akero study finds

How Brent Saunders' Allergan experiment failed

Change Healthcare: What is it, why does its cyberattack matter?

Ozempic has benefits for kidney disease as well as diabetes

Longer MASH drug regimen improved liver, Akero study finds

entertainment

focus

Wikipedia

Wikipedia